Biocryst Pharma Inc (BCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -108,897 | -101,252 | -65,782 | -55,144 | -43,019 |
| Depreciation Amortization | 841 | 1,765 | 1,737 | 1,564 | 1,189 |
| Accounts receivable | -17,853 | 1,824 | 2,651 | -2,525 | 3,247 |
| Other Working Capital | -872 | -3,530 | 9,327 | -7,551 | 18,445 |
| Other Operating Activity | 37,197 | 8,628 | 10,924 | 10,218 | 7,022 |
| Operating Cash Flow | $-89,584 | $-92,565 | $-41,143 | $-53,438 | $-13,116 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 78,277 | 5,134 | -64,326 | 28,546 | -11,420 |
| PPE Investments | -343 | -366 | -316 | -5,273 | -5,122 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -1,462 |
| Investing Cash Flow | $77,934 | $4,768 | $-64,642 | $23,273 | $-18,004 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 19,477 | 10,353 | N/A | 22,658 | N/A |
| Debt Repayment | N/A | -4,025 | N/A | N/A | N/A |
| Common Stock Issued | 59,739 | 56,252 | 135,581 | 317 | 5,479 |
| Other Financing Activity | 19,882 | -76 | 122 | 329 | 0 |
| Financing Cash Flow | $99,098 | $62,504 | $135,703 | $23,304 | $5,479 |
| Beginning Cash Position | 28,275 | 53,568 | 23,650 | 30,511 | 54,540 |
| End Cash Position | 115,723 | 28,275 | 53,568 | 23,650 | 28,899 |
| Net Cash Flow | $87,448 | $-25,293 | $29,918 | $-6,861 | $-25,641 |
| Free Cash Flow | |||||
| Operating Cash Flow | -89,584 | -92,565 | -41,143 | -53,438 | -13,116 |
| Capital Expenditure | -343 | -366 | -328 | -5,277 | -5,122 |
| Free Cash Flow | -89,927 | -92,931 | -41,471 | -58,715 | -18,238 |